AXGN Q2 2019 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q2 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$27M+29.7% YoY

Gross Profit

$22M84.1% margin

Operating Income

-$8M-28.7% margin

Net Income

-$7M-26.3% margin

EPS (Diluted)

$-0.18

QoQ Revenue Growth

+14.7%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$7M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$157M

Total Liabilities

$19M

Stockholders' Equity

$138M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$27M	$21M	+29.7%
Gross Profit	$22M	$17M	+28.5%
Operating Income	-$8M	-$5M	-59.2%
Net Income	-$7M	-$7M	+5.4%